sodium,5-(difluoromethoxy)-2-[(S)-(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide
-
![sodium,5-(difluoromethoxy)-2-[(S)-(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220812/f8ca9dc32d484ff7825c5548fe212f00.png "sodium,5-(difluoromethoxy)-2-[(S)-(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide")
sodium,5-(difluoromethoxy)-2-[(S)-(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide
structure -
-
CAS No:
160488-53-9
-
Formula:
C16H14F2N3NaO4S
-
Chemical Name:
sodium,5-(difluoromethoxy)-2-[(S)-(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide
- Categories:
-
CAS No:
Description
2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
sodium,5-(difluoromethoxy)-2-[(S)-(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide Basic Attributes
405.35200
405.05707772
605-368-1
DTXSID60668221
Safety Information
|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P301+P312, P330, and P501|Aggregated GHS information provided by 111 companies from 7 notifications to the ECHA C&L Inventory.|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Drug Information
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)|Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)
BY 1023
sodium,5-(difluoromethoxy)-2-[(S)-(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide Use and Manufacturing
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:405.4
Hydrogen Bond Acceptor Count:10
Rotatable Bond Count:7
Exact Mass:405.05707772
Monoisotopic Mass:405.05707772
Topological Polar Surface Area:90.8
Heavy Atom Count:27
Complexity:497
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Recommended Suppliers of sodium,5-(difluoromethoxy)-2-[(S)-(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide
-
![China]()
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamineInquiryCAS No.: 160488-53-9Grade: Industrial GradeContent: 99%
Latest News on sodium,5-(difluoromethoxy)-2-[(S)-(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide
Learn More Other Chemicals
-
5-BROMOISOPHTHALALDEHYDE
120173-41-3
-
1-BROMO-3-IODO-5-TRIFLUOROMETHYL-BENZENE
481075-59-6
-
1-BROMO-1,1,2,2-TETRAFLUORO-4-IODOBUTANE
129587-49-1
-
4-BROMO-3-METHOXYANILINE Formula
19056-40-7
-
3-Bromo-6,8-dichloro-4H-1-benzopyran-4-one Formula
263365-49-7
-
1-BROMO-8-IODONAPHTHALENE Formula
4044-58-0
-
4-BROMO-3,5-DICHLOROFLUOROBENZENE Structure
263333-82-0
-
4-Bromo-2-methylisoindolin-1-one Structure
435273-55-5
-
What is 3-Bromopyrazine-2-carboxylic acid
937669-80-2
-
What is 3-Bromomethylbenzenesulfonyl chloride
148583-69-1
Request for Quotation